Prevention of tuberculosis reactivation

Brett K, Severn M
Record ID 32018002248
English
Authors' objectives: Questions: - What is the clinical utility of screening for latent tuberculosis infection in people at risk of tuberculosis reactivation? - What is the clinical effectiveness of treating latent tuberculosis infection to prevent tuberculosis reactivation? - What are the evidence-based guidelines for the prevention of tuberculosis reactivation?
Details
Project Status: Completed
Year Published: 2021
URL for additional information: https://cadth.ca/tuberculosis
English language abstract: An English language summary is available
Publication Type: Rapid Review
Country: Canada
MeSH Terms
  • Tuberculosis
  • Disease Susceptibility
  • Latent Tuberculosis
  • Preventive Medicine
  • Health Promotion
Keywords
  • Tuberculosis
  • Health promotion
  • Reactivation
Contact
Organisation Name: Canadian Agency for Drugs and Technologies in Health
Contact Address: 600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name: requests@cadth.ca
Contact Email: requests@cadth.ca
Copyright: <p>Canadian Agency for Drugs and Technologies in Health (CADTH)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.